Explore our Insights
Federal Court of Appeal Clarifies Test for Inducing Infringement for Generic/Biosimilar Drugs›
Chirality Matters: Dismissal of Janssen’s Judicial Review Confirms Enantiomers Are Not “Innovative Drugs” for Obtaining Data Protection›
Patented Medicines Regulations: The Problem Is Not in Collecting the Data, but in How You Use It!›
USSC Agrees to Reconsider Amgen Inc. v Sanofi on Enablement of Antibody Genus Claims›
Subscribe to our newsletter
Showing results 1 - 24 of 40 Results per page:
No results found.